GlassScriptPhysician profile
Yaneth Estrada
NPI 1922080027
$1,578.94
in general payments reported to CMS, 2019-2025
9 companies · $353 in 2025
The $353 reported for 2025 was more than what a typical Primary Podiatric Medicine provider received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $141 · 2022: $252 · 2023: $275 · 2024: $558 · 2025: $353.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,186.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $399.83 | 2023-2024 | Xarelto |
| Glaxosmithkline, LLC. | $238.95 | 2022-2025 | |
| Edwards Lifesciences Corporation | $157.84 | 2024 | Sapien 3 Ultra Resilia |
| Abbott Laboratories | $152.97 | 2024 | Freestyle Libre 3 |
| Apellis Pharmaceuticals, INC. | $143.31 | 2025 | |
| Novo Nordisk INC | $140.54 | 2019 | |
| Medtronic, INC. | $127.23 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $122.51 | 2024 | |
| Solventum Corporation | $95.76 | 2025 | Activ.A.C. |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yaneth Estrada listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.